Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2025-12-31 00:00:00 ET · period of report 2025-12-30 · accession 0001225471-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-31 | 2025-12-30 | REGN | SING GEORGE L | Dir | M - OptEx | $520.01 | +9,212 | 37.0K | +33% | +$4.79M |
| D | 2025-12-31 | 2025-12-30 | REGN | SING GEORGE L | Dir | F - Tax | $774.03 | -6,188 | 30.9K | -17% | -$4.79M |
| D | 2025-12-31 | 2025-12-30 | REGN | SING GEORGE L | Dir | M - OptEx | $0.00 | -9,212 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-30 | M | A | 9,212 | $520.01 | 37,040 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-30 | F | D | 6,188 | $774.03 | 30,852 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-12-30 | M | D | 9,212 | $0.00 | 0 | D | $520.01 · — to 2026-01-04 | 9,212 Common Stock | (F1) The stock option vested in three equal annual installments, commencing one year after the date of grant. |